—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Spyre Therapeutics Inc. (SYRE) — Technical state

As of 2026-10-06 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

Pullback inside an uptrend stack

Trades -16% vs the 50-day and +17.5% vs the 200-day average, 27.3% below the 52-week high and +405.1% off the 52-week low. Computed from daily closes.

Ranked #3 on today’s Directional Flow — on a pullback list (scan of 2026-10-06).

The moving-average stack

Continue: the SYRE chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-10-06

Quick answers

What is the current Closelooknet signal on SYRE?

Pullback inside an uptrend stack — Trades -16% vs the 50-day and +17.5% vs the 200-day average, 27.3% below the 52-week high and +405.1% off the 52-week low. Computed from daily closes. As of 2026-10-06; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is SYRE above its 50-day and 200-day moving averages?

As of 2026-10-06, Spyre Therapeutics Inc. trades -16% below its 50-day and +17.5% above its 200-day average, with the 20-day -10.1% away.

How far is SYRE from its 52-week high?

27.3% below the 52-week high and 405.1% above the 52-week low, as of 2026-10-06.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.